Art and Science of Laboratory Medicine

Art and Science of Laboratory Medicine
Showing posts with label virology. Show all posts
Showing posts with label virology. Show all posts

Saturday, November 12, 2016

This USB Stick can perform an HIV Test

Scientists in the UK have developed a USB stick that can quickly and accurately measure the amount of HIV is in a patient’s blood.

The medical device was created by scientists at Imperial College London and tech firm DNA Electronics, and all it needs is a simple drop of blood to measure HIV-1 levels. It then creates an electrical signal that’s fed into a computer, laptop, or handheld device. The disposable test could be used by HIV patients to monitor their own treatment and help patients in remote regions of the world, where more standard HIV tests are inaccessible.

The timely detection of viremia in HIV-infected patients receiving antiviral treatment is key to ensuring effective therapy and preventing the emergence of drug resistance. In high HIV burden settings, the cost and complexity of diagnostics limit their availability. Scientists in the UK have developed a novel complementary metal-oxide semiconductor (CMOS) chip based, pH-mediated, point-of-care HIV-1 viral load monitoring assay that simultaneously amplifies and detects HIV-1 RNA. A novel low-buffer HIV-1 pH-LAMP (loop-mediated isothermal amplification) assay was optimised and incorporated into a pH sensitive CMOS chip. Screening of 991 clinical samples (164 on the chip) yielded a sensitivity of 95% (in vitro) and 88.8% (on-chip) at >1000 RNA copies/reaction across a broad spectrum of HIV-1 viral clades. Median time to detection was 20.8 minutes in samples with >1000 copies RNA. The sensitivity, specificity and reproducibility are close to that required to produce a point-of-care device which would be of benefit in resource poor regions, and could be performed on an USB stick or similar low power device.

Read more:
Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia

Source: Nature: Scientific reports
Image: Imperial College London/DNA Electronics

Sunday, November 6, 2016

Saturday, September 3, 2016

Tick-borne Hemorrhagic Fever Kills Man in Spain

Spanish health authorities said on Thursday they were investigating a possible outbreak of Crimean-Congo hemorrhagic fever (CCHF) which has killed one man and infected a nurse, in the first non-imported case reported in Western Europe.

The 62-year-old man died on Aug. 25 after contracting the CCHF disease during a walk in the Castilla-Leon region, probably from a tick bite he reported - which is one of the main ways it is transmitted - authorities said in a statement.

He also infected the nurse who treated him at a hospital in Madrid and she is now in a stable condition in quarantine at an isolation unit, they said. Authorities are monitoring about 200 other people who had come into contact with the man and nurse.

According to the World Health Organization, CCHF's mortality rate is about 30 percent and it is endemic to Africa, the Balkans and Ukraine, the Middle East and Central Asia.

Read more:
First Local Case of Tick-Borne Disease Kills Man in Spain

Source: Scientific American
Image: ALL OVER PRESS

Influenza D

A new influenza virus that affects cattle has an official name. influenza D. The executive committee of the International Committee of Taxonomy of Virus approved a new genus, Orthomyxovirdae, with a single species, Influenza D virus, because of its distinctness from other influenza types—A, B and C.

The research group showed that influenza D is spread only through direct contact and proved a guinea pig can be used as an animal model to study the virus. Influenza D antibodies have been identified in blood samples from sheep and goats, but the virus does not affect poultry.

Studies are underway to compare the virulence among the bovine and swine influenza D strains and human influenza C using the guinea pig model. If the virus can undergo reassortment in combination with a closely related human influenza virus, it may be able to form a new strain that could pose more of a threat to humans.

Read more:
 New Virus Gets Official Name, Influenza D

Source: Newswice

Monday, August 29, 2016

CDC: Sexual Transmission of Zika Possible Without Symptoms

The Centers for Disease Control and Prevention (CDC) today released the first solid evidence that a man infected with Zika, but who never develops symptoms, can sexually transmit the virus to a female partner.

An article published online in the agency's Morbidity and Mortality Weekly Report (MMWR) described the case of a woman who contracted Zika after having condomless vaginal intercourse and fellatio with a male partner after he came back from the Dominican Republic, where mosquitos are spreading the virus. The man said he had been exposed to mosquitos during his travels, but had not experienced fever, rash, conjunctivitis, or other hallmarks of Zika before or after returning to the United States. He said he had felt fatigued, but chalked that up to travel.

The man subsequently tested positive for antibodies against both Zika virus and dengue virus. The woman, who developed fever, rash, and other Zika symptoms, tested positive for Zika virus RNA in her urine.

Read more:
CDC: Sexual Transmission of Zika Possible Without Symptoms

Soure: Medscape
Image: Davina diaries

Wednesday, August 24, 2016

Status of laboratory testing for HIV

Two years have passed since the CDC finally published guidelines addressing HIV laboratory testing and officially endorsed the “new” HIV laboratory testing algorithm. Although many had become aware of the algorithm in the four years prior, and had adopted it to various degrees, this was the final word on this long-awaited guidance. The algorithm gained visibility prior to the official endorsement mainly because it had been heavily referenced in CDC publications and numerous scientific articles.

View algorithm here

The new algorithm, however, has presented some real challenges for the laboratory. The biggest adjustment to adopting the new algorithm has been replacing the Western blot with an HIV-1/HIV-2 differentiation assay. The only assay with this capability until recently was the Multispot (Bio-Rad). However, the Multispot is no longer available and will be replaced with Bio-Rad’s Geenius. Although the Geenius is also a single use test (FDA-cleared) for confirming reactive HIV screen results and differentiating between HIV-1 and HIV-2 antibodies, it differs from the Multispot in a number of important aspects. The test uses either recombinant or synthetic peptides corresponding to four HIV-1 antigens, gp160, gp41, p31 and p24, and two corresponding to HIV-2 antigens, gp140 and gp36. There are eight possible interpretations based on the pattern observed. Performance characteristics are comparable to Multispot. Sensitivity is 100 percent for both assays, and specificity values are 99.1 percent and 96.3 percent for the Multispot and Geenius, respectively. The results can be read within 30 minutes and are interpreted using an automated cassette reader, therefore eliminating inter-observer subjectivity. The cassette system also allows for placement of a bar code label on each specimen, improving sample tracking. Additionally, because software is necessary for interpretation, the results are digitally captured, automatically recorded, and stored.

Read more:
The status of laboratory testing for the diagnosis of HIV infection


Source: MLO

Tuesday, August 16, 2016

Mosquito-Borne Diseases

Mosquitoes cause more human suffering than any other organism -- over one million people worldwide die from mosquito-borne diseases every year. Not only can mosquitoes carry diseases that afflict humans, they also transmit several diseases and parasites that dogs and horses are very susceptible to. These include dog heartworm, West Nile virus (WNV) and Eastern equine encephalitis (EEE). In addition, mosquito bites can cause severe skin irritation through an allergic reaction to the mosquito's saliva - this is what causes the red bump and itching. Mosquito vectored diseases include protozoan diseases, i.e., malaria, filarial diseases such as dog heartworm, and viruses such as dengue, encephalitis and yellow fever. CDC Travelers' Health provides information on travel to destinations where human-borne diseases might be a problem.
  • Malaria
  • Chikungunya
  • Dog Heartworm
  • Dengue
  • Yellow Fever
  • Eastern Equine Encephalitis
  • St. Louis Encephalitis
  • LaCrosse Encephalitis
  • Western Equine Encephalitis
  • West Nile Virus
  • Zika Virus
Read more:
Mosquito-Borne Diseases

Source: AMCA
Image: NIH

Monday, February 29, 2016

High-resolution picture of coronaviruses entering cells

High-resolution cryo-electron microscopy and supercomputing have now made it possible to analyze in detail the infection mechanisms of coronaviruses. These viruses are notorious for attacking the respiratory tract of humans and animals.

A research team that included scientists from the University of Washington (UW), the Pasteur Institute and the University of Utrecht has obtained an atomic model of a coronavirus spike protein that promotes entry into cells. Analysis of the model is providing ideas for specific vaccine strategies. The study results are outlined in a recent UW Medicine-led study published in Nature. David Veesler, UW assistant professor of biochemistry, headed the project.

Read more:
Structure that coronaviruses use to enter cells is unveiled

Source: UW HSNewsBeat

Wednesday, February 24, 2016

Influenza viruses can hide from the immune system

Influenza is able to mask itself, so that the virus is not initially detected by our immune system. This is the result of new research from Aarhus University. The researchers behind the study hope that the discovery can be used to develop better treatment against influenza and chronic inflammation conditions such as rheumatoid arthritis.

Some years ago researchers discovered that the immune system can already track viruses and alert the body as soon as a virus enters human cells to multiply. But new research now reveals that the influenza virus cheats the mechanism and is thus able to circumvent the body's advanced defence system.

"The virus contains a protein that masks the virus entering the cell. In this way, the influenza virus can spread more easily before the immune system recognises that it is a virus and attempts to fight it," says Associate Professor Christian Holm from the Department of Biomedicine at Aarhus University.''

Together with Professor Søren R. Paludan, he has headed the research project, which has also comprised contributions from other researchers at Aarhus University and from a number of American universities. Their discovery has recently been published in the scientific journal Nature Communications.

Read more:
Influenza virus can hide from the immune system

Source: Aarhus University

Saturday, February 6, 2016

ZIKA virus

Member of the Flaviviridae family and Flavivirus genus. There are 68 arboviruses in Flavivirus genus, of them 34 are transmitted by mosquitos, 19 by ticks and the rest are transmitted by bats or rodents.

Flaviviruses are as big as 40 – 50 nm and they have single stranded RNA. They are round with lipoprotein envelope and glikoproteins. These viruses are sensitive to organic solvents, UV light, 3% formaldehyde, 2% glutaraldehyde, γ rays; and they dissolve at 56°C/30 min. They can be contained at -60°C for a longer period of time.

The reproduction:

  • Flavivirus enters the host cell with endocitosis after connecting the E-protein on cell receptors. The fusion of the virus envelope and membrane brings to the release of nucleocapsid in the cytoplasm of the host cell. That's where the translation of the RNA genome occures. The nucleus of the cell is not part of the virus replication process. All virus proteins are formed as long poliproteins (with more than 3000 aminoacids) which are then cut into smaller proteins with the help of viruses and cells protease. Flaviviruses develop by budding through the intercelular membrane into the cytoplasm vesicles, which merge to the celular membrane of the infected cell and the matured virus is released into the outer environment. [1]
Some of the other diseases caused by Flaviviruses are the Western Nile virus, dengue virus, yellow fever virus, the japanese encephalitis virus, the Murray Valley encephalitis and St. Louis encephalitis virus.

Image: Zika virus risk in Europe by ECDC, WHO


The more recent outbrake of the Flavivirus is the ZIKA virus.

Zika virus was first introduced in 1947 when it was isolated from a rhesus monkey in Uganda who developed a fewer after being put in a cage in the Zika forrest for monitoring the sylvatic yellow fewer. First isolation of this virus found in humans was in 1952. In 2007 there were about 100 cases of zika virus known outside of Africa and Asia with no hospitalization or deaths. In 2013 – 2015 there's been new outbrake of the zika virus that continues to the 2016. The outbrake started in Brazil and is transmitted by Aedes aegypti mosquitos (they also transmit dengue, chikungunya and yellow fever).[2]

The most common symptomes are fever, rash, joint pain, or conjunctivitis (red eyes). Other common symptoms include muscle pain and headache. Very similar to the dengue. The incubation period (time from exposure to symptomes) is not known but is likely to be few days. Some people never develop any symptomes. However there are doubts if it is connected to the birth defects such as microcephaly in recently born children. Since the outbrake in Brazil there have been few reports on the Guillain-Barré syndrome (disorder in which the body's immune system attacks part of the peripheral nervous system). The hospitalization is uncommon and deaths are rare. [3]

Diagnosis of zika is done through PCR (polymerase chain reaction) and the virus infected blood samples. However it's rather difficult to detect and name the virus since it can cross-react with other flaviviruses such as dengue, West Nile and yellow fever.[4]

WHO advises the infected countries to start the extermination of the mosquitos. Until then it's important to protect yourself from mosquito bites by: wearing clothes that hide as much of the body as it's possible, sleeping under mosquito nets, using anti-insect creames, closing the windows and doors.

Zika virus disease is usually relatively mild and requires no specific treatment. However there's no vaccine available yet.



Ines Poljak
student of Medical Laboratory Diagnostics, ZVU, Croatia


References:
[1] G. Mlinarić Galinović, M. Ramljak Šešo; Special medical microbiology and parasitology; ZVU, Zagreb 2013.
[2] paho.org
[3] cdc.gov
[4] who.int

Thursday, February 4, 2016

Can Zika virus be sexually transmitted?

Vincent Racaniell says in Virology blog "Perhaps in very rare cases, but the main mode of transmission is certainly via mosquitoes. If you just read the news headlines, which many people do, you will think that Zika virus spreads like HIV. But it does not."

The first hint of sexual transmission of Zika virus came from the story of two American scientists working in Senegal in 2008, where they were sampling mosquitoes. Between 6-9 days after returning to their homes in Colorado, they developed a variety of symptoms of infection including fatigue, headache, chills, arthralgia, and a maculopapular rash. The wife of one patient had not traveled to Africa, yet she developed similar symptoms three days after her husband. Analysis of paired acute and convalescent sera from all three patients revealed antibodies against Zika virus. The authors of the study do not conclude that transmission from husband to wife was via sexual activity – they suggest it as a possiblity.

Just as we are not sure that Zika virus causes microencephaly, we are not sure if it can be sexually transmitted.

Read more:
Zika from sex is the byway, not the highway

Source: Virology blog
Image credits: Getty Images

Thursday, January 28, 2016

Zika Virus Update

Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes aegypti mosquitoes. Zika virus was incidentally discovered in Uganda in 1947 during mosquito and primate surveillance. It was named for the forest in Uganda where it was first discovered. Until recently Zika virus remained confined to a few countries in across Africa and into Asia and circulated predominantly in wild primates and Aedes africanus mosquitos. Human infections were rare.

More recently, Zika virus has spread from Africa into several countries in Latin America along with the Aedes aegypti mosquito. Brazilian officials estimate that between 440,000 and 1,300,000 cases have occurred in 2015. In 2016, Zika virus transmission has been reported in 19 other countries or territories in the Americas. Western Hemisphere countries and territories include Colombia, El Salvador, French Guiana, Guatemala, Haiti, Honduras, Martinique, Mexico, Panama, Puerto Rico, Paraguay, Suriname and Venezuela. 

Read more:
Zika Virus Update

Source: ClinLab Navigator
Image credits: CDC

Tuesday, January 26, 2016

New Tests for Zika Virus

As reports of Zika virus infections continue to spread through the Americas, countless questions loom. Chief among them is about the relationship between infection during pregnancy and microcephaly in babies, which has been difficult to pin down given the limitations of current diagnostics. A number of researchers are working at breakneck speed to develop immunological reagents and assays that could confirm whether a person has had a Zika infection.

Currently, the standard assay for Zika viral infection is a PCR test that probes for the presence of viral RNA in a sample.

More user-friendly serologic tests, which measure the presence of antibodies against a particular pathogen, would be a better alternative, but in the case of Zika it’s been difficult to tell which flavivirus a person has encountered—whether dengue, Zika, or another. “And the problem is, where Zika is occurring is the same place dengue is occurring,” said immunobiologist Mike Diamond of Washington University in St. Louis.

Several commercial outfits are selling serologic Zika tests. For instance, San Diego–based MyBioSource sells an IgM ELISA to test for Zika. Biocan Diagnostics, based in Canada, is selling a finger-prick assay that can detect IgM and IgG antibodies (which are elevated even longer after an infection than IgM antibodies) against Zika and give results in five to 10 minutes. “It can be used in field settings or mobile clinics, and doesn’t need any special equipment,” said Bhavjit Jauhar, the vice president of sales and development for Biocan. He said his firm’s screening test is 99 percent specific, with no cross-reactivity with dengue or chikungunya.

Read more:
New Tests for Zika in the Works 

Source: TheScientist Magazine

Thursday, January 14, 2016

Zika virus is raising global alarm

Britain's Oxford University warned that a virus known as Zika, which is carried by mosquitoes and has caused a major outbreak in Brazil, has "the potential of rapid spread to new areas."

Zika was first detected in Africa in the 1940s and was unknown in the Americas until last year, but has now been confirmed in Brazil, Panama, Venezuela, El Salvador, Mexico, Suriname, the Dominican Republic, Colombia, Guatemala and Paraguay, according to public health officials. It is carried by the Aedes aegypti mosquito, which thrives in tropical climates and can also carry other diseases such as yellow fever, dengue fever and chikungunya.

Thousands of people in Brazil have been infected by Zika. While the virus is not thought to kill, health authorities there last year linked it to a surge in babies born with microcephaly, restricted head growth that seriously limits a child's mental and physical abilities.

Read more:
After Ebola, Two Other Tropical Diseases Pose New Threats



Source: Medscape

Tuesday, August 25, 2015

Lemon juice and human norovirus

Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center. Therefore, lemon juice could be a potentially safe and practical disinfectant against the most common pathogen of severe gastrointestinal infections.

"Maybe a few drops of lemon juice on contaminated food or surfaces may prevent the transmission of these viruses." 

Read more:
Lemon juice and human norovirus

Source: dkfz

Monday, May 11, 2015

Virus Classification

Since their initial discovery of viruses in 1898, about 5,000 viruses have been described in detail, although there are millions of different types.

These non-cellular human pests typically contain one of two types of genomes, made up of either short strands of DNA or RNA. Shortly after a virus enters a cell, it is usually the synthetic machinery of the host cell that allows the virus to create specialized elements called capsid that allow their genome to transferred to other cells efficiently.

Read more:
Viruses » Pathogen Profile Dictionary

Source: Pathogen Profile Dictionary

Friday, May 8, 2015

Remembering Mumps

The mumps virus belongs to the family of paramyxoviruses. It has a single-strand, nonsegmented, negative-sense RNA genome and is spread by the respiratory route. Following a 12–25-day incubation period, infection frequently causes the classic symptom of mumps: painfully swollen parotid salivary glands (parotitis). Some complications of infection include hearing loss, orchitis, oophoritis, mastitis, and pancreatitis. Mumps may also result in aseptic meningitis and, infrequently, encephalitis (5%–10% and <0.5% of unvaccinated cases, respectively). Importantly it has been estimated that as many as 30% of infections in unvaccinated individuals may be asymptomatic.

Read more:
Remembering Mumps

 Source: PLOS

Thursday, April 30, 2015

Americas region is declared the world’s first to eliminate rubella

The Americas region has become the first in the world to be declared free of endemic transmission of rubella, a contagious viral disease that can cause multiple birth defects as well as fetal death when contracted by women during pregnancy.

This achievement culminates a 15-year effort that involved widespread administration of the vaccine against measles, mumps and rubella (MMR) throughout the Western Hemisphere. The announcement comes as 45 countries and territories of the Americas are participating in the 13th annual Vaccination Week in the Americas (April 25 to May 2).

Read more:
Americas region is declared the world’s first to eliminate rubella

Source: WHO


Tuesday, April 28, 2015

HIV home test kit

An early diagnosis allows people to get treatment quickly and can prevent serious complications. And individuals successfully treated for HIV are less likely to pass the infection on. This new "do-it-yourself" test is made by company Bio Sure UK and can be bought online.

It works in a similar way to a pregnancy test, measuring levels of antibodies - proteins made in response to the virus - in a person's blood. The device analyses a small droplet of blood, taken from the finger-tip using a lancet. Two purple lines appear if it is positive. The company recommends attending sexual health clinics for advice and further blood tests if both lines appear.

Read more:
HIV home test kit goes on sale in UK

Source: BBC


Wednesday, March 11, 2015

CDC New HIV Testing Algorithm

In June 2014, CDC recommended a new approach for HIV testing in laboratories, which capitalizes on the latest technology to improve the diagnosis of acute infection. The recommendations feature a new testing algorithm that allows the diagnosis of acute HIV infection as much as 3-4 weeks earlier than the previous testing approach.

The new algorithm begins with a combination immunoassay that detects HIV-1 and HIV-2 antibodies and HIV-1 p24 antigen. This test is more sensitive in diagnosing early infection because it detects the HIV-1 p24 antigen, which appears before antibodies develop.

Specimens reactive on the screening fourth-generation assay are tested with a supplemental assay that differentiates HIV-1 and HIV-2 antibodies. Specimens that are reactive on the initial fourth-generation assay but nonreactive or indeterminate on the antibody differentiation assay are then tested for HIV-1 RNA to differentiate acute HIV infection from a false-positive screening result.

Read more:
New HIV Testing Algorithm

CDC Recommendations
Laboratory Testing for the Diagnosis of HIV Infection - Updated Recommendations

 Source: CDC

Follow "Art and Science of Laboratory Medicine " on:


https://www.facebook.com/LaboratoryEQAS
https://twitter.com/LaboratoryEQAS
https://plus.google.com/100408138227362094524/posts
http://www.pinterest.com/labmed/medical-laboratory-and-biomedical-science/
http://www.linkedin.com/in/jwahlstedt
http://clinical-laboratory.blogspot.com/feeds/posts/default